comparemela.com

Latest Breaking News On - புரட்சி சுகாதாரம் கையகப்படுத்தல் கார்ப் - Page 1 : comparemela.com

10 Best SPACs to Buy According to SoftBank s Masayoshi Son

10 Best SPACs to Buy According to SoftBank s Masayoshi Son
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Some big U S hedge funds loaded up on SPACS, value stocks during first quarter

Some big U.S. hedge funds loaded up on SPACS, value stocks during first quarter By David Randall Reuters NEW YORK (Reuters) - A number of well-known U.S. hedge funds bought value stocks and blank-check acquisition companies, selling some winners from the technology-led stock rally as bond yields rose during the first quarter, filings released on Monday showed. Special-purpose acquisition companies, known as SPACs, proved popular among hedge fund managers, with funds such as Third Point and Saschem Head adding shares of SPACs, including FinTech Acquisition Corp V and healthcare company Orion Acquisition Corp to their portfolios. Tiger Global added shares of Revolution Healthcare Acquisition Corp and Soaring Eagle Acquistion Corp and trimmed its position in Facebook Inc.

Is $500 Million Enough for a Biotech-Focused SPAC?

ch 22, Fool.com contributors Brian Orelli and Keith Speights discuss whether $500 million will be enough and what the SPAC can do to help boost the capital available to whatever company it eventually decides to take public. Brian Orelli: Revolution Healthcare Acquisition Corp. only raised $500 million, which, to be honest, isn t a whole lot of money for a biotech these days. Do you think they can find something that cheap. You can talk about the other mechanisms that SPACs use to bolster their investments beyond with this SPAC actually has in cash. Keith Speights: Yeah, I think that s the really big question here. Will Revolution Healthcare, first of all, be able to find any company that really meet their vision of what they re trying to achieve here, and can they do it for $500 million? That s going to be hard, I think. To do so, they might have to find some really early stage companies, again, that just introduces more risk to the equation. But you re right, $500 million is not

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.